Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (651-660 of 6,834) with videos related to

Pageof 684
Sort By:
The Journal of Prosthetic Dentistry|August 1, 1971
Six honest serving men for medical writersR Asher
Nature Reviews. Drug Discovery|February 11, 2026
PD1 blockers work best when used in the morning, suggests cancer chronotherapy trialAsher Mullard
Nature Reviews. Drug Discovery|January 14, 2026
First antibody-mimetic adnectin nabs an FDA approvalAsher Mullard
Nature Reviews. Drug Discovery|May 7, 2025
FDA approves cell-sheet-based gene therapy for severe skin diseaseAsher Mullard
Nature Reviews. Drug Discovery|January 2, 2025
2024 FDA approvalsAsher Mullard
Nature Reviews. Drug Discovery|September 6, 2023
FDA approves first GPRC5D × CD3-targeted bispecific for multiple myelomaAsher Mullard
Nature Reviews. Drug Discovery|December 9, 2024
Can non-canonical amino acids open up non-canonical drug discovery opportunities?Asher Mullard
Nature Reviews. Drug Discovery|October 13, 2023
CAR T cell therapies raise hopes - and questions - for lupus and autoimmune diseaseAsher Mullard
Nature Reviews. Drug Discovery|October 23, 2023
Glue-based KRAS inhibitors make their debut cancer trial markAsher Mullard
Nature Reviews. Drug Discovery|October 25, 2023
Drug developers back US$80 million African ancestry genomics initiativeAsher Mullard
Pageof 684

Showing results (651-660 of 6,834) with videos related to

Sort By:
Pageof 684
The Journal of Prosthetic Dentistry|August 1, 1971
Six honest serving men for medical writersR Asher
Nature Reviews. Drug Discovery|February 11, 2026
PD1 blockers work best when used in the morning, suggests cancer chronotherapy trialAsher Mullard
Nature Reviews. Drug Discovery|January 14, 2026
First antibody-mimetic adnectin nabs an FDA approvalAsher Mullard
Nature Reviews. Drug Discovery|May 7, 2025
FDA approves cell-sheet-based gene therapy for severe skin diseaseAsher Mullard
Nature Reviews. Drug Discovery|January 2, 2025
2024 FDA approvalsAsher Mullard
Nature Reviews. Drug Discovery|September 6, 2023
FDA approves first GPRC5D × CD3-targeted bispecific for multiple myelomaAsher Mullard
Nature Reviews. Drug Discovery|December 9, 2024
Can non-canonical amino acids open up non-canonical drug discovery opportunities?Asher Mullard
Nature Reviews. Drug Discovery|October 13, 2023
CAR T cell therapies raise hopes - and questions - for lupus and autoimmune diseaseAsher Mullard
Nature Reviews. Drug Discovery|October 23, 2023
Glue-based KRAS inhibitors make their debut cancer trial markAsher Mullard
Nature Reviews. Drug Discovery|October 25, 2023
Drug developers back US$80 million African ancestry genomics initiativeAsher Mullard
Pageof 684